$122.63 -2.45 (%) Vertex Pharmaceuticals Inc - NASDAQ

May. 26, 2015 | 04:00 PM

Partner Headlines

  1. 5 Drugs That Could Be Summer Blockbusters

    IBD | May. 26, 2015 | 08:02AM EST
  2. Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter

    GuruFocus | May. 20, 2015 | 14:16PM EST
  3. Stocks: Quiet Open Ahead Of Fed; Dycom Rockets, Airlines Ruffled

    IBD | May. 20, 2015 | 10:42AM EST
  4. Stocks Open To Quiet Gains; Williams, Pall And Zebra Spike

    IBD | May. 13, 2015 | 10:44AM EST
  5. Tuesday's After-Hours Movers: Vertex Pharmaceuticals, Orexigen Therapeutics And More

    Benzinga | May. 12, 2015 | 21:22PM EST
  6. Panel OKs cystic fibrosis med

    IBD | May. 12, 2015 | 19:03PM EST
  7. Vertex CF Drug Orkambi Wins FDA Advisory Panel Vote

    IBD | May. 12, 2015 | 17:10PM EST
  8. Stocks Finish Lower; GoDaddy Down After Hours On Earnings

    IBD | May. 12, 2015 | 17:03PM EST
  9. FDA Advisory Panel Vote Inconclusive on Whether Vertex's Lumacaftor Contributes Positively to Orkambi's Effectiveness

    Benzinga | May. 12, 2015 | 15:30PM EST
  10. Gilead's Strong Profit Tops Mixed Drug maker Reports

    IBD | Apr. 30, 2015 | 18:50PM EST
  11. Apple Supplier Among 3 Top Earnings Reports Tonight

    IBD | Apr. 29, 2015 | 15:09PM EST
  12. Gilead Sciences

    IBD | Apr. 21, 2015 | 18:48PM EST
  13. Short Sellers Come Back To Biotech Stocks

    Benzinga | Feb. 26, 2015 | 13:25PM EST
  14. Short Sellers Retreat From Biotech Stocks

    Benzinga | Feb. 12, 2015 | 08:23AM EST
  15. Super Bowl Stocks: Seattle's Best Vs. Boston Strong

    IBD | Jan. 31, 2015 | 08:02AM EST
  16. Baird Releases Comments After Vertex Earnings Call

    Benzinga | Jan. 29, 2015 | 15:08PM EST
  17. Alexion Beats Q4 Estimates, Appoints New CEO

    IBD | Jan. 29, 2015 | 13:28PM EST
  18. Maxim Downgrades Vertex Pharmaceuticals After Earnings

    Benzinga | Jan. 29, 2015 | 12:00PM EST
  19. Morning Market Losers

    Benzinga | Jan. 29, 2015 | 10:00AM EST
  20. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 29, 2015 | 08:20AM EST
  21. Vertex Pharmaceuticals Beats Q4 Revenue Expectations

    Benzinga | Jan. 28, 2015 | 17:39PM EST
  22. Earnings Scheduled For January 28, 2015

    Benzinga | Jan. 28, 2015 | 05:02AM EST
  23. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga | Jan. 26, 2015 | 14:34PM EST
  24. Vertex CEO On Company's New Cystic Fibrosis Drug, Pricing Strategy

    Benzinga | Jan. 14, 2015 | 10:40AM EST
  25. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  26. J.P. Morgan Chimes In With Ratings On BioTech Stocks

    GuruFocus | Jan. 6, 2015 | 12:46PM EST
  27. UPDATE: Barclays Capital Initiates Coverage On Vertex Pharmaceuticals On Leading Position In CF Market

    Benzinga | Jan. 6, 2015 | 10:24AM EST
  28. BTIG Initiates Coverage On Vertex Pharmaceuticals, Notes Company's Cystic Fibrosis Therapies

    Benzinga | Jan. 5, 2015 | 19:11PM EST
  29. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
  30. William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

    GuruFocus | Dec. 23, 2014 | 14:47PM EST
  31. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 22, 2014 | 08:18AM EST
  32. Don't Overlook Mid-Cap Stocks

    Benzinga | Dec. 11, 2014 | 18:14PM EST
  33. Great News For Biogen, But What's Next For The Stock?

    Benzinga | Dec. 3, 2014 | 12:36PM EST
  34. Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex ...

    GuruFocus | Nov. 9, 2014 | 15:20PM EST
  35. Bank Of America Is Impressed By Takeaways From Vertex Pharmaceuticals Conference Call

    Benzinga | Oct. 14, 2014 | 07:59AM EST
  36. UPDATE: Piper Jaffray Upgrades Vertex Pharmaceuticals Ahead Of Expected Combination Approvals

    Benzinga | Oct. 13, 2014 | 08:45AM EST
  37. Big Swings in Biotech Short Interest

    Benzinga | Oct. 13, 2014 | 08:32AM EST
  38. Piper Jaffray Upgrades Vertex Pharmaceuticals To Overweight

    Benzinga | Oct. 13, 2014 | 08:09AM EST
  39. H.C. Wainwright Highlights Its Top Picks Ahead Of NACFC 2014

    Benzinga | Oct. 1, 2014 | 10:15AM EST
  40. J&J Buying Alios, Going Up Against Gilead

    IBD | Sep. 30, 2014 | 12:02PM EST
  41. Fast Money Picks For September 26 - Pfizer Inc., The Dow Chemical Company And More

    Benzinga | Sep. 25, 2014 | 20:26PM EST
  42. Stocks End Skid; Vertex, Alexion Lead Biotech Rebound

    IBD | Sep. 24, 2014 | 16:16PM EST
  43. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 24, 2014 | 09:58AM EST
  44. These 3 Biotech Stocks Just Hit New Highs

    Benzinga | Sep. 22, 2014 | 13:31PM EST
  45. Midday Gainers From September 19 - Alibaba Group Holding Ltd, Concur Technologies, Inc. And More

    Benzinga | Sep. 19, 2014 | 14:13PM EST
  46. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD | Aug. 8, 2014 | 16:45PM EST
  47. Stocks Gain, Techs Take Lead; Autohome, BitAuto Top IBD 50

    IBD | Aug. 4, 2014 | 10:28AM EST
  48. Vertex Is Poised For An Earnings Breakout

    Benzinga | Jul. 23, 2014 | 15:56PM EST
  49. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD | Jul. 3, 2014 | 17:08PM EST
  50. Analyst Concerns On Vertex's Approved Drug

    Benzinga | Jun. 25, 2014 | 09:14AM EST
Trading Center